Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 12,260 shares at $53.68 ($614K) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($614k) by EVP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.22 | 10,000 | $492K | 80.2% |
| 2 | $53.68 | 1,130 | $61K | 9.9% |
| 3 | $53.68 | 1,130 | $61K | 9.9% |
| Total | $50.04 avg | 12,260 | $614K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |